24 May 2018 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) is urging consumers not to use OTC teething products containing benzocaine because they "pose a serious risk" to infants and children younger than two years.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.